Funding for this research was provided by:
jiangsu hengrui pharmaceuticals co., ltd.
Received: 23 June 2021
Accepted: 28 February 2022
First Online: 14 March 2022
: The study was approved by the Ethics Committee of Peking Union Medical College Hospital on October 27, 2020 (approval number: HS-2617). Written informed consent is obtained from each participant before enrollment.
: Not applicable.
: The authors declare that they have no competing interests.